v3.22.1
CONDENSED INTERIM STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
OPERATING EXPENSES.    
Research and Development $ 818,888 $ 91,908
General and Administrative 1,851,250 1,382,421
TOTAL OPERATING EXPENSES 2,670,138 1,474,329
NET LOSS $ (2,670,138) $ (1,474,329)
LOSS PER SHARE    
Basic net loss per common share/units $ (0.26) $ (0.21)
Diluted net loss per common share/units $ (0.26) $ (0.21)
Weighted average common shares/units outstanding basic 10,232,843 6,867,289
Weighted average common shares/units outstanding diluted 10,232,843 6,867,289

Source